Novartis AG
METHODS FOR PREVENTING AND TREATING HEART DISEASE
Last updated:
Abstract:
The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2021
Issue date:
7 Oct 2021